In a case of hypertensive uveitis, most useful drug to reduce intraocular pressure is –
**Core Concept**
The question tests the student's knowledge of managing hypertensive uveitis, a condition characterized by increased intraocular pressure (IOP) and inflammation of the uvea. **Hypertensive uveitis** requires a careful approach to reduce IOP while considering the underlying inflammatory process. The management involves **anti-inflammatory** and **intraocular pressure-lowering** medications.
**Why the Correct Answer is Right**
Since the correct answer is not provided, let's consider a common approach to managing hypertensive uveitis. Typically, medications that reduce IOP, such as **prostaglandin analogs**, **beta-blockers**, **carbonic anhydrase inhibitors**, or **alpha agonists**, are used. However, in the context of uveitis, it's crucial to control inflammation.
**Why Each Wrong Option is Incorrect**
**Option A:** Without knowing the specific option, we can't comment on its correctness.
**Option B:** Similarly, without the option, it's hard to justify its incorrectness.
**Option C:** and **Option D:** would be incorrect if they didn't address the dual need of reducing IOP and managing inflammation in hypertensive uveitis.
**Clinical Pearl / High-Yield Fact**
A key point in managing hypertensive uveitis is to balance IOP reduction with control of inflammation, often requiring a combination of **steroids** for inflammation and **IOP-lowering medications**.
**Correct Answer:** Not provided in the query.